Silicon Valley’s Quest for Designer Babies Is Here
Silicon Valley’s wealthiest are embracing advanced embryo screening to select everything from disease resistance to height. With IVF tech investment hitting $2B in 2024, the line between medical necessity and genetic optimization is blurring fast.













































